ALZ researcher Dr. Reisa Sperling will be featured on the next conference call sponsored by USAgainstAlzheimer’s. The invitation and registration information I received are below; this is a free event open to anyone.
Past conference calls are also archived and available on the website.
What if we could stop Alzheimer’s before symptoms begin? That’s just what esteemed researcher Dr. Reisa Sperling is trying to find out.
Dr. Sperling is the featured guest for this month’s edition of Alzheimer’s Talks on Friday, March 15 from 4:00 – 5:00 pm Eastern.
Dr. Sperling is leading a groundbreaking new study on individuals whose brain scans show plaque buildups but do not yet demonstrate clinical symptoms of Alzheimer’s or other dementias. She will be testing the effectiveness of the Eli Lilly drug solanezumab, which in previous studies has shown might have promise with people that have a milder form of Alzheimer’s.
Join us on Friday, March 15 from 4:00 – 5:00 pm Eastern to hear about Dr. Sperling’s latest research developments, ask questions of a leading Alzheimer’s researcher, and find out how you can get more involved in the fight to stop this disease.
Dr. Sperling is the Director of the Center for Alzheimer’s Research and Treatment, the Director of the Education and Information Transfer Core, Massachusetts Alzheimer’s Disease Research Center, Co-Leader of the Neuroimaging Program, Massachusetts Alzheimer’s Disease Research Center, and a Professor of Neurology at Harvard Medical School.
Alzheimer’s Talks is a monthly teleconference series to help individuals better understand Alzheimer’s so we can be smarter as we raise our voices and advocate for bold initiatives to stop the disease. It’s presented by USAgainstAlzheimer’s and is free and open to the public.
Thank you for all that you do to bring an end to this disease.
Chairman and Co-Founder
P.S. Please note that everyone who registers will be called on Friday, March 15 at 4:00 pm Eastern and will be connected automatically to the free teleconference.